Longitudinal HIV Risk Behavior Among the Drug Abuse Treatment Outcome Studies (DATOS) Adult Sample

Abstract

Longitudinal trajectories for HIV risk were examined over 5 years following treatment among 1,393 patients who participated in the nationwide Drug Abuse Treatment Outcome Studies. Both injection drug use and sexual risk behavior declined over time, with most of the decline occurring between intake and the first-year follow-up. However, results of the application of growth mixture models for both sets of trajectories indicated that a subgroup of individuals reverted to a high-risk behavior over time, with a higher level of risk at the 5-year follow-up than their original risk level at intake. Of clients who were engaged in regular injection drug use at intake, 76% continued to inject drug at a moderate—stable or increased rate during the 5-year follow-up.

Keywords

HIV risk behavior injection drug use sexual risk behavior

Get full access to this article

View all access options for this article.

References

Abdul-Quader, A.S. , S.R. Friedman , D. Des Jarlais , M.M. Marmor , R. Maslansky , and S. Bartelme. 1988. Methadone maintenance and behavior by intravenous drug users. Contemporary Drug Problems 14:425-34.

Baker, A. , N. Heather , A. Wodak , J. Dixon , and P. Holt. 1993. Evaluation of a cognitive-behavioural intervention for HIV prevention among injecting drug users. AIDS 7:247-56.

Ball, J.C. , W.R. Lange , C.P. Myers , and S.R. Friedman. 1988. Reducing the risk of AIDS through methadone maintenance treatment. Journal of Health and Social Behavior 29: 214-26.

Broome, K.M. , G.W. Joe , and D.D. Simpson. 1999. HIV risk reduction in outpatient drug abuse treatment: Individual and geographic differences. AIDS Education and Prevention 11:293-306.

Bryan, A.D. , J.D. Fisher , W.A. Fisher , and D.M. Murray. 2000. Understanding condom use among heroin addicts in methadone maintenance using the information-motivation-behavioral skills model. Substance Use and Misuse 35:451-71.

Camacho, L.M. , N.G. Bartholomew , G.W. Joe , and M.A. Cloud. 1996. Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance. Drug and Alcohol Dependence 41:1-7.

Centers for Disease Control and Prevention. 2003. Basic statistics. Atlanta, GA: National Center for HIV, STDs, and TB Prevention, Divisions of HIV/AIDS Prevention .

Dasgupta, S. , S.R. Friedman , B. Jose , and A. Neaigus. 1995. Using retrospective behavioral data to determine HIV risk factors among street-recruited drug injectors. Journal of Drug Issues 25:161-71.

Derogatis, L.R. , R.S. Lipman , and L. Covi. 1973. SCL-90: An outpatient psychiatric rating scale—Preliminary report. Psychopharmacology Bulletin 9:13-28.

10.

Etheridge, R.M. , R.L. Hubbard , J. Anderson , S.G. Craddock , and P.M. Flynn. 1997. Treatment structure and program services in the drug abuse treatment outcome study (DATOS). Psychology of Addictive Behaviors 11:244-60.

11.

Flynn, P.M. , S.G. Craddock , R.L. Hubbard , J. Anderson , and R.M. Etheridge. 1997. Methodological overview and research design for the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors 11:230-43.

12.

Gossop, M. , J. Marsden , D. Stewart , and S. Treacy. 2002. Change and stability of change after treatment of drug misuse: 2-year outcomes from the national treatment outcome research study (UK). Addictive Behaviors 27:155-66.

13.

Helal, H. , I. Momas , S. Pretet , L. Marsal , and R. Poinsard. 1995. HIV prevalence and risk behaviour among intravenous drug users attending HIV counselling and testing centres in Paris . Addiction 90:1627-33.

14.

Hoffman, J.A. , H. Klein , D.C. Clark , and F.T. Boyd. 1998. The effect of entering drug treatment on involvement in HIV-related risk behaviors. American Journal of Drug and Alcohol Abuse 24:259-84.

15.

Hou, S. , and K. Basen-Engquist . 1997. Human immunodeficiency virus risk behavior among White and Asian/Pacific islander high school students in the United States: Does culture make a difference? Journal of Adolescent Health 20:68-74.

16.

Hser, Y. , M.E. Stark , A. Paredes , D. Huang , M.D. Anglin , and R. Rawson. 2006. A 12-year follow-up of a treated cocaine-dependent sample. Journal of Substance Abuse Treatment 30:219-26.

17.

Hubbard, R.L. , S.G. Craddock , and J. Anderson. 2003. Overview of 5-year followup outcomes in the Drug Abuse Treatment Outcome Studies (DATOS). Journal of Substance Abuse Treatment 25:125-34.

18.

Hubbard, R.L. , S.G. Craddock , P.M. Flynn , J. Anderson , and R.M. Etheridge. 1997. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcomes Study (DATOS). Psychology of Addictive Behaviors 11:261-78.

19.

Klee, H. , J. Faugier , C. Hayes , and J. Morris. 1991. The sharing of injecting equipment among drug users attending prescribing clinics and those using needle-exchanges . British Journal of Addiction 86:217-23.

20.

Latka, M.H. , T.E. Wilson , J.A. Cook , M.C. Bacon , J.L. Richardson , N. Sohler , M.H. Cohen , R.M. Greenblatt , E. Andreopoulis , and D. Vlahov. 2005. Impact of drug treatment on subsequent sexual risk behavior in a multisite cohort of drug using women: A report from the Women's Interagency HIV Study. Journal of Substance Abuse Treatment 29:329-37.

21.

Longshore, D. , and S. Hsieh. 1998. Drug abuse treatment and risky sex: Evidence for a cumulative treatment effect? American Journal of Drug and Alcohol Abuse 24:439-51.

22.

Marmor, M. , D.C. Des Jarlais , S.R. Friedman , M. Lyden , and W. el-Sadr. 1984. The epidemic of acquired immunodeficiency syndrome (AIDS) and suggestions for its control in drug abusers. Journal of Substance Abuse Treatment 1:237-47.

23.

Metzger, D.S. , and H. Navaline. 2003. Human immunodeficiency virus prevention and the potential of drug abuse treatment. Clinical Infectious Diseases 37 (suppl. 5): S451-56.

24.

Metzger, D.S. , H. Navaline , and G.E. Woody. 1998. Drug abuse treatment as AIDS prevention . Public Health Reports 113 (suppl. 1): 97-106.

25.

Muthen, B. 2004. Latent variable analysis: Growth mixture modeling and related techniques for longitudinal data. In Handbook of quantitative methodology for the social sciences, ed. D. Kaplan , 345-68. Thousand Oaks, CA: Sage.

26.

Muthen, B. , and L. Muthen. 2000. Integrating person-centered and variable-centered analysis: Growth mixture modeling with latent trajectory classes. Alcoholism: Clinical and Experimental Research 24:882-91.

27.

———. 2004. Mplus user's guide. Los Angeles: Author.

28.

Muthen, B. , and K. Shedden. 1999. Finite mixture modeling with mixture outcomes using the EM algorithm. Biometrica 55:463-69.

29.

Nagin, D.S. 1999. Analyzing developmental trajectories: A semiparametric, group-based approach. Psychological Methods 4:139-57.

30.

———. 2005. Group-based modeling of development. Cambridge, MA: Harvard University Press.

31.

Neaigus, A. , S.R. Friedman , R. Curtis , and D.C. Des Jarlais . 1994. The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Social Science and Medicine 38:67-78.

32.

Neaigus, A. , M. Sufian , S.R. Friedman , D.S. Goldsmith , B. Stepherson , P. Mota , J. Pascal , and D.C. Des Jarlais . 1990. Effects of outreach intervention on risk reduction among intravenous drug users. AIDS Education and Prevention 2:253-71.

33.

Robins, L.N. , J.E. Helzer , J.L. Croughan , and K.S. Ratcliff. 1981. National Institute of Mental Health Diagnostic Interview Schedule: Its history, characteristics, and validity . Archives of General Psychiatry 38:381-89.

34.

Robins, L.N. , J.K. Wing , and J.E. Helzer. 1983. Composite International Diagnostic Interview (CIDI). Geneva, Switzerland: World Health Organization .

35.

Schilling, R.F. , N. El-Bassel , L. Gilbert , and S.P. Schinke. 1991. Correlates of drug use, sexual behavior, and attitudes toward safer sex among African-American and Hispanic women in methadone maintenance. Journal of Drug Issues 21:685-98.

36.

Shah, N.G. , N. Galai , D.D. Celentano , D. Vlahov , and S.A. Strathdee. 2006. Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD 1988-2000. Drug and Alcohol Dependence 83:147-56.

37.

Shoptaw, S. , C.J. Reback , D.L. Frosch , and R.A. Rawson. 1998. Stimulant abuse treatment as HIV prevention . Journal of Addictive Diseases 17:19-32.

38.

Simpson, D.D. , G.W. Joe , B.W. Fletcher , R.L. Hubbard , and M.D. Anglin. 1999. A national evaluation of treatment outcomes for cocaine dependence. Archives of General Psychiatry 56:507-14.

39.

Stephens, R.C. , D.D. Simpson , S.L. Coyle , and C.B. McCoy. 1993. Comparative effectiveness of NADR interventions . In Handbook on risk of AIDS: Injection drug users and sexual partners, ed. B. Brown and G. Beschner , 9-25. Westport, CT: Greenwood.

40.

van Empelen, P. , G. Kok , N.M.C. van Kesteren , B. van den Borne , A.E.R. Bos , and H.P. Schaalma. 2003. Effective methods to change sex-risk among drug users: A review of psychosocial interventions. Social Science and Medicine 57:1593-1608.

41.

Watkins, K.E. , D. Metzger , G.E. Woody , and A.T. McLellan. 1992. High-risk sexual behaviors of intravenous drug users in- and out-of-treatment: Implications for the spread of HIV infection . American Journal of Drug and Alcohol Abuse 18:389-98.

42.

Woods, W.J. , J.R. Guydish , J.L. Sorensen , A. Coutts , A. Bostrom , and A. Acampora. 1999. Changes in HIV-related risk behaviors following drug abuse treatment. AIDS 13:2151-55.